Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Christopher Hawkey

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Gastric Mucosa

Procedures

Double-Blind Method

Disorders

Living Beings

Helicobacter pylori

Concepts & Ideas

Risk Factors

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
17
Cole, AT
13
Yeomans, Neville
12
Stack, WA
11
Naesdal, Jørgen
10
Fortun, Paul
9
Atherton, John
7
Filipowicz, B
7
Logan, Richard
6
Långström, Göran
6
Mahida, Yashwant
6
Cullen, DJ
5
Krammer, Gerhard
5
Gitton, Xavier
5
Peacock, RA
5
Ragunath, Krish

Sign-in to see all Coauthors

Publications

TOP 3
Hawkey C J
NSAIDs and aspirin: notorious or FAMOUS?
Subramanian Venkataraman; Hawkey Christopher J
Assessing bleeds clinically: what's the score?
Hawkey Christopher J; Svedberg Lars-Erik; Naesdal Jørgen; Byrne Claire
Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Christopher Hawkey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hawkey C J
NSAIDs and aspirin: notorious or FAMOUS?
Lancet 2009;374(9684):93-4.
2009: Subramanian Venkataraman; Hawkey Christopher J
Assessing bleeds clinically: what's the score?
Lancet 2009;373(9657):5-7.
2009: Hawkey Christopher J; Svedberg Lars-Erik; Naesdal Jørgen; Byrne Claire
Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.
Clinical drug investigation 2009;29(10):677-87.
2008: Hawkey Christopher J
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA : the journal of the American Medical Association 2008;300(8):901; author reply 904-5.
2008: Fortun P; West J; Chalkley L; Shonde A; Hawkey C
Recall of informed consent information by healthy volunteers in clinical trials.
QJM : monthly journal of the Association of Physicians 2008;101(8):625-9.
2008: Singh R; Anagnostopoulos G K; Yao K; Karageorgiou H; Fortun P J; Shonde A; Garsed K; Kaye P V; Hawkey C J; Ragunath K
Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology.
Endoscopy 2008;40(6):457-63.
2008: Hawkey Christopher J; Ell Christian; Simon Bernd; Albert Jörg; Keuchel Martin; McAlindon Mark; Fortun Paul; Schumann Stefan; Bolten Wolfgang; Shonde Anthony; Hugot Jean-Louis; Yu Vincent; Arulmani Udayasankar; Krammer Gerhard; Rebuli Rosemary; Toth Ervin
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(5):536-44.
2008: Hawkey C J; Weinstein W M; Stricker K; Murphy V; Richard D; Krammer G; Rebuli R
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial.
Alimentary pharmacology & therapeutics 2008;27(9):838-45.
2007: Anagnostopoulos G K; Yao K; Kaye P; Hawkey C J; Ragunath K
Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging.
Alimentary pharmacology & therapeutics 2007;26(3):501-7.
2007: Hawkey Christopher J; Weinstein Wilfred M; Smalley Walter; Gitton Xavier; Sallstig Peter; Stricker Kirstin; Krammer Gerhard; Mellein Bernhard; Richard Dominik; Matchaba Patrice
Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.
Gastroenterology 2007;133(1):57-64.
2007: Chew Eng-Hui; Poobalasingam Thurka; Hawkey Christopher J; Hagen Thilo
Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization.
Cellular signalling 2007;19(5):1071-80.
2007: Hawkey C J; Jones R H; Yeomans N D; Scheiman J M; Talley N J; Goldstein J L; Ahlbom H; Naesdal J
Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs.
Alimentary pharmacology & therapeutics 2007;25(7):813-21.
2007: Fortun Paul J; Hawkey Christopher J
Nonsteroidal antiinflammatory drugs and the small intestine.
Current opinion in gastroenterology 2007;23(2):134-41.
2007: Hawkey Christopher J; Talley Nicholas J; Scheiman James M; Jones Roger H; Långström Göran; Naesdal Jorgen; Yeomans Neville D;
Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies.
Arthritis research & therapy 2007;9(1):R17.
2006: Anagnostopoulos George-K; Ragunath Krish; Shonde Anthony; Hawkey Christopher J; Yao Kenshi
Diagnosis of autoimmune gastritis by high resolution magnification endoscopy.
World journal of gastroenterology : WJG 2006;12(28):4586-7.
2006: Hawkey C J; Hawkey G M; Everitt S; Skelly M M; Stack W A; Gray D
Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs.
British journal of clinical pharmacology 2006;61(6):730-7.
2006: Scheiman James M; Yeomans Neville D; Talley Nicholas J; Vakil Nimish; Chan Francis K L; Tulassay Zsolt; Rainoldi Jorge L; Szczepanski Leszek; Ung Kjell-Arne; Kleczkowski Dariusz; Ahlbom Henrik; Naesdal Jørgen; Hawkey Christopher
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
The American journal of gastroenterology 2006;101(4):701-10.
2006: Fortun P J; Anagnostopoulos G K; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey C J; Ragunath K
Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
Alimentary pharmacology & therapeutics 2006;23(6):735-42.
2006: Hawkey Christopher J; Gitton Xavier; Hoexter Godehard; Richard Dominik; Weinstein Wilfred M
Gastrointestinal tolerability of lumiracoxib in patients with osteoarthritis and rheumatoid arthritis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(1):57-66.
2005: Hawkey C J
COX-2 chronology.
Gut 2005;54(11):1509-14.
2005: Yeomans N D; Lanas A I; Talley N J; Thomson A B R; Daneshjoo R; Eriksson B; Appelman-Eszczuk S; Långström G; Naesdal J; Serrano P; Singh M; Skelly M M; Hawkey C J
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin.
Alimentary pharmacology & therapeutics 2005;22(9):795-801.
2005: Hawkey Christopher J; Fortun Paul J
Cyclooxygenase-2 inhibitors.
Current opinion in gastroenterology 2005;21(6):660-4.
2005: Tata L J; Fortun P J; Hubbard R B; Smeeth L; Hawkey C J; Smith C J P; Whitaker H J; Farrington C P; Card T R; West J
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
Alimentary pharmacology & therapeutics 2005;22(3):175-81.
2005: Anagnostopoulos G K; Fortun P; Ragunath K; Hawkey C J
Images of interest. Gastrointestinal: early endoscopic findings in watermelon stomach identified by the magnifying endoscopy-adaptive IHb color enhancement technique.
Journal of gastroenterology and hepatology 2005;20(7):1122.
2005: Fortun P J; Hawkey C J
Life after Vioxx: the clinical implications.
Hospital medicine (London, England : 1998) 2005;66(5):264-7.
2005: Hawkey Chris; Talley Nicholas J; Yeomans Neville D; Jones Roger; Sung Joseph J Y; Långström Göran; Naesdal Jørgen; Scheiman James M;
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors.
The American journal of gastroenterology 2005;100(5):1028-36.
2005: Fortun Paul James; Hawkey Christopher John
Nonsteroidal antiinflammatory drugs and the small intestine.
Current opinion in gastroenterology 2005;21(2):169-75.
2004: Farkouh Michael E; Kirshner Howard; Harrington Robert A; Ruland Sean; Verheugt Freek W A; Schnitzer Thomas J; Burmester Gerd R; Mysler Eduardo; Hochberg Marc C; Doherty Michael; Ehrsam Elena; Gitton Xavier; Krammer Gerhard; Mellein Bernhard; Gimona Alberto; Matchaba Patrice; Hawkey Christopher J; Chesebro James H;
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
Lancet 2004;364(9435):675-84.
2004: Schnitzer Thomas J; Burmester Gerd R; Mysler Eduardo; Hochberg Marc C; Doherty Michael; Ehrsam Elena; Gitton Xavier; Krammer Gerhard; Mellein Bernhard; Matchaba Patrice; Gimona Alberto; Hawkey Christopher J;
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.
Lancet 2004;364(9435):665-74.
2004: Hawkey C J
Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?
Alimentary pharmacology & therapeutics 2004;20 Suppl 2():59-64.
2004: Hawkey C J; Farkouh M; Gitton X; Ehrsam E; Huels J; Richardson P
Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics.
Alimentary pharmacology & therapeutics 2004;20(1):51-63.
2004: Hawkey Christopher J
Stem cell transplantation for Crohn's disease.
Best practice & research. Clinical haematology 2004;17(2):317-25.
2004: Atherton Clare; Jones John; McKaig Brian; Bebb James; Cunliffe Rob; Burdsall Jake; Brough Joanne; Stevenson Diane; Bonner Johanne; Rordorf Christiane; Scott Graham; Branson Janice; Hawkey Christopher J
Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(2):113-20.
2004: Pathmakanthan Shri; Li Chris K F; Cowie Jonathan; Hawkey Christopher J
Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon.
Journal of gastroenterology and hepatology 2004;19(2):166-73.
2003: Hawkey C J; Jones J I; Atherton C T; Skelly M M; Bebb J R; Fagerholm U; Jonzon B; Karlsson P; Bjarnason I T
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans.
Gut 2003;52(11):1537-42.
2003: Wiklund I K; Fullerton S; Hawkey C J; Jones R H; Longstreth G F; Mayer E A; Peacock R A; Wilson I K; Naesdal J
An irritable bowel syndrome-specific symptom questionnaire: development and validation.
Scandinavian journal of gastroenterology 2003;38(9):947-54.
2003: Jackson L; Wahli W; Michalik L; Watson S A; Morris T; Anderton K; Bell D R; Smith J A; Hawkey C J; Bennett A J
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer.
Gut 2003;52(9):1317-22.
2003: James Martin W; Hawkey Christopher J
Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.
British journal of clinical pharmacology 2003;56(2):146-55.
2003: Dallob Aimee; Hawkey Christopher J; Greenberg Howard; Wight Nicholas; De Schepper Paul; Waldman Scott; Wong Peggy; DeTora Lisa; Gertz Barry; Agrawal Nancy; Wagner John; Gottesdiener Keith
Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
Journal of clinical pharmacology 2003;43(6):573-85.
2003: Skelly M M; Hawkey C J
COX-LOX inhibition: current evidence for an emerging new therapy.
International journal of clinical practice 2003;57(4):301-4.
2003: Hawkey C J; Atherton J C; Treichel H C; Thjodleifsson B; Ravic M
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Alimentary pharmacology & therapeutics 2003;17(8):1065-74.
2003: Hawkey C J; Langman M J S
Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors.
Gut 2003;52(4):600-8.
2003: Jonzon Bror; Bjarnason Ingvar; Hawkey Chris; Jones John; Goddard Andrew; Fagerholm Urban; Karlsson Pär
The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers.
Inflammopharmacology 2003;11(4):437-44.
2003: Skelly M M; Hawkey C J
Dual COX inhibition and upper gastrointestinal damage.
Current pharmaceutical design 2003;9(27):2191-5.
2002: Hawkey C J; Wilson I; Naesdal J; Långström G; Swannell A J; Yeomans N D
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Gut 2002;51(3):344-50.
2002: Hawkey C J; Naesdal J; Wilson I; Långström G; Swannell A J; Peacock R A; Yeomans N D
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Gut 2002;51(3):336-43.
2002: Stack W A; Atherton J C; Hawkey G M; Logan R F A; Hawkey C J
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
Alimentary pharmacology & therapeutics 2002;16(3):497-506.
2002: Hawkey C J; Skelly M M
Gastrointestinal safety of selective COX-2 inhibitors.
Current pharmaceutical design 2002;8(12):1077-89.
2001: Hawkey C J; Jones J I
Gastrointestinal safety of COX-2 specific inhibitors.
Gastroenterology clinics of North America 2001;30(4):921-36.
2001: Hawkey C J
NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials? The gastroenterologist's perspective.
Clinical and experimental rheumatology 2001;19(6 Suppl 25):S23-30.
2001: Hawkey C J
COX-1 and COX-2 inhibitors.
Best practice & research. Clinical gastroenterology 2001;15(5):801-20.
2001: Hawkey C J; Laine L; Harper S E; Quan H U; Bolognese J A; Mortensen E;
Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials.
Alimentary pharmacology & therapeutics 2001;15(10):1593-601.
2001: Hawkey G M; Cole A T; McIntyre A S; Long R G; Hawkey C J
Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.
Gut 2001;49(3):372-9.
2001: Stack W A; Richardson P D; Logan R P; Mahida Y R; Hawkey C J
Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine.
The American journal of gastroenterology 2001;96(7):2255-6.
2001: Longstreth G F; Hawkey C J; Mayer E A; Jones R H; Naesdal J; Wilson I K; Peacock R A; Wiklund I K
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials.
Alimentary pharmacology & therapeutics 2001;15(7):959-64.
2001: Kubba A K; Selby N M; Hawkey C J
Update in the pharmacological management of peptic ulcer haemorrhage.
Scandinavian journal of gastroenterology 2001;36(4):337-42.
2001: Wight N J; Gottesdiener K; Garlick N M; Atherton C T; Novak S; Gertz B J; Calder N A; Cote J; Wong P; Dallob A; Hawkey C J
Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production.
Gastroenterology 2001;120(4):867-73.
2001: Hawkey C J; Lanas A I;
Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.
The American journal of medicine 2001;110(1A):79S-100S.
2001: Hawkey C J
Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction.
The American journal of medicine 2001;110(1A):1S-3S.
2001: Hawkey C J; Jackson L; Harper S E; Simon T J; Mortensen E; Lines C R
Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans.
Alimentary pharmacology & therapeutics 2001;15(1):1-9.
2001: Yeomans N; Wilson I; Långström G; Hawkey C; Naesdal J; Walan A; Wiklund I
Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.
Scandinavian journal of rheumatology 2001;30(6):328-34.
2000: Yeomans N D; Garas G; Hawkey C J
The nonsteroidal anti-inflammatory drugs controversy.
Gastroenterology clinics of North America 2000;29(4):791-805.
2000: Jackson L M; Wu K C; Mahida Y R; Jenkins D; Hawkey C J
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa.
Gut 2000;47(6):762-70.
2000: Pathmakanthan S; Hawkey C J
A lay doctor's guide to the inflammatory process in the gastrointestinal tract.
Postgraduate medical journal 2000;76(900):611-7.
2000: Selby N M; Kubba A K; Hawkey C J
Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'.
Alimentary pharmacology & therapeutics 2000;14(9):1119-26.
2000: Hawkey C J
Nonsteroidal anti-inflammatory drug gastropathy.
Gastroenterology 2000;119(2):521-35.
2000: Hawkey C J
Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?
BMJ (Clinical research ed.) 2000;321(7256):291-3.
2000: Hawkey C J
What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
European journal of gastroenterology & hepatology 2000;12 Suppl 1():S17-20.
2000: Jackson L M; Hawkey C J
COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?
Drugs 2000;59(6):1207-16.
2000: Hawkey C J; Snowden J A; Lobo A; Beglinger C; Tyndall A
Stem cell transplantation for inflammatory bowel disease: practical and ethical issues.
Gut 2000;46(6):869-72.
2000: Donnelly M T; Richardson P; Hawkey C J; Courtauld E; Stack W A
Dose-dependent effects of ketoprofen on the human gastric mucosa in comparison with ibuprofen.
Alimentary pharmacology & therapeutics 2000;14(5):543-9.
2000: Donnelly M T; Goddard A F; Filipowicz B; Morant S V; Shield M J; Hawkey C J
Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury.
Alimentary pharmacology & therapeutics 2000;14(5):529-34.
2000: Hawkey C J
Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs.
Baillière's best practice & research. Clinical gastroenterology 2000;14(1):173-92.
2000: Seager J M; Cullen D J; Pearson G; Holmes S; Doherty M; Wilson J V; Garrud P; Garner S; Maynard A; Logan R F; Hawkey C J
Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception.
Alimentary pharmacology & therapeutics 2000;14(2):187-91.
2000: Cullen D J; Seager J M; Holmes S; Doherty M; Wilson J V; Garrud P; Garner S; Maynard A; Logan R F; Hawkey C J
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices.
Alimentary pharmacology & therapeutics 2000;14(2):177-85.
1999: Hawkey C J
Irritable bowel syndrome clinical trial design: future needs.
The American journal of medicine 1999;107(5A):98S-102S.
1999: Jackson L M; Hawkey C J
NSAIDs and the GI tract-potential hazards and benefits.
Apoptosis : an international journal on programmed cell death 1999;4(5):397-402.
1999: Hull M A; Thomson J L; Hawkey C J
Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells.
Gut 1999;45(4):529-36.
1999: Hawkey C J
Is Helicobacter pylori eradication useful in patients taking NSAIDs?
European journal of gastroenterology & hepatology 1999;11 Suppl 2():S47-50; discussion S73.
1999: Beltinger J; McKaig B C; Makh S; Stack W A; Hawkey C J; Mahida Y R
Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response.
The American journal of physiology 1999;277(2 Pt 1):C271-9.
1999: Jackson L M; Hawkey C J
Gastrointestinal effects of COX-2 inhibitors.
Expert opinion on investigational drugs 1999;8(7):963-71.
1999: Hawkey C J
Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance.
Alimentary pharmacology & therapeutics 1999;13(6):695-702.
1999: McKaig B C; Makh S S; Hawkey C J; Podolsky D K; Mahida Y R
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3.
The American journal of physiology 1999;276(5 Pt 1):G1087-93.
1999: Duggan A E; Stack W; Hull M; Filipowicz B; Knifton A; Crome R; Weber C; Bishop A; Polak J; Hawkey C J
Protection against aspirin-induced human gastric mucosal injury by bosentan, a new endothelin-1 receptor antagonist.
Alimentary pharmacology & therapeutics 1999;13(5):631-5.
1999: Beltinger J; Hawkey C J; Stack W A
TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells.
The American journal of physiology 1999;276(4 Pt 1):C848-55.
1999: Wu K C; Jackson L M; Galvin A M; Gray T; Hawkey C J; Mahida Y R
Phenotypic and functional characterisation of myofibroblasts, macrophages, and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells.
Gut 1999;44(3):323-30.
1999: Cole A T; Hudson N; Liew L C; Murray F E; Hawkey C J; Heptinstall S
Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?
Alimentary pharmacology & therapeutics 1999;13(2):187-93.
1999: Taha A S; Dahill S; Morran C; Hudson N; Hawkey C J; Lee F D; Sturrock R D; Russell R I
Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.
Gastroenterology 1999;116(2):254-8.
1999: Hawkey C J
COX-2 inhibitors.
Lancet 1999;353(9149):307-14.
1998: Stack W A; Jenkins D; Vivet P; Hawkey C J
Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial. The Platelet Activating Factor Antagonist Study Group in Ulcerative Colitis.
Gastroenterology 1998;115(6):1340-5.
1998: Hull M A; Brough J L; Powe D G; Carter G I; Jenkins D; Hawkey C J
Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.
Gut 1998;43(4):525-36.
1998: Stack W A; Long R G; Hawkey C J
Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.
Alimentary pharmacology & therapeutics 1998;12(10):973-8.
1998: Stack W A; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey C J; Atherton J C
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
The American journal of gastroenterology 1998;93(10):1909-13.
1998: Hawkey C J
Naproxen sodium did not lead to substantially more upper gastrointestinal tract bleeding than ibuprofen during short term use as an analgesic.
Gut 1998;43(3):315.
1998: Richardson P; Hawkey C J; Stack W A
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.
Drugs 1998;56(3):307-35.
1998: Hawkey C J; Tulassay Z; Szczepanski L; van Rensburg C J; Filipowicz-Sosnowska A; Lanas A; Wason C M; Peacock R A; Gillon K R
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
Lancet 1998;352(9133):1016-21.
1998: Parry S D; Perkins A C; Hawkey C J
A case of pica and iron deficiency anaemia in Nottingham.
International journal of clinical practice 1998;52(5):354-5.
1998: Duggan A E; Tolley K; Hawkey C J; Logan R F
Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model.
BMJ (Clinical research ed.) 1998;316(7145):1648-54.
1998: Logan R P; Robins A; Turner G A; Cockayne A; Borriello S P; Hawkey C J
A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells.
Journal of immunological methods 1998;213(1):19-30.
1998: Hawkey C J; Yeomans N D
Evolving strategies for managing nonsteroidal anti-inflammatory drug-associated ulcers: chairmen's conclusion.
The American journal of medicine 1998;104(3A):96S.
1998: Hawkey C J
Practical management: a keypad-based interactive session.
The American journal of medicine 1998;104(3A):89S-95S.
1998: Hawkey C J
Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
The American journal of medicine 1998;104(3A):67S-74S; discussion 79S-80S.
1998: Hawkey C J; Yeomans N D
Evolving strategies for managing nonsteroidal anti-inflammatory drug-associated ulcers: chairmen's introduction.
The American journal of medicine 1998;104(3A):1S.
1998: Hawkey C J; Karrasch J A; Szczepañski L; Walker D G; Barkun A; Swannell A J; Yeomans N D
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
The New England journal of medicine 1998;338(11):727-34.
1998: Yeomans N D; Tulassay Z; Juhász L; Rácz I; Howard J M; van Rensburg C J; Swannell A J; Hawkey C J
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
The New England journal of medicine 1998;338(11):719-26.
1998: Cullen D; Bardhan K D; Eisner M; Kogut D G; Peacock R A; Thomson J M; Hawkey C J
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
Alimentary pharmacology & therapeutics 1998;12(2):135-40.
1998: Hawkey C J
Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
Italian journal of gastroenterology and hepatology 1998;30(1):48-9.
1998: Duggan A E; Hardy E; Hawkey C J
Evaluation of a new Near Patient Test for the detection of Helicobacter pylori.
European journal of gastroenterology & hepatology 1998;10(2):133-6.
1997: Mahida Y R; Beltinger J; Makh S; Göke M; Gray T; Podolsky D K; Hawkey C J
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2.
The American journal of physiology 1997;273(6 Pt 1):G1341-8.
1997: Stack W A; Hawkey C J
Specific mediator-directed therapy for gastrointestinal diseases.
European journal of gastroenterology & hepatology 1997;9(11):1056-61.
1997: Cullen D J; Hawkey G M; Greenwood D C; Humphreys H; Shepherd V; Logan R F; Hawkey C J
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
Gut 1997;41(4):459-62.
1997: Duggan A E; Atherton J C; Cockayne A; Balsitis M; Evison S; Hale T; Hawkey C J; Spiller R C
Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study.
The British journal of nutrition 1997;78(4):515-22.
1997: May J A; Heptinstall S; Cole A T; Hawkey C J
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
Thrombosis research 1997;88(2):183-92.
1997: Hudson N; Murray F E; Cole A T; Filipowicz B; Hawkey C J
Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.
Gut 1997;41(1):19-23.
1997: Hawkey C J
The gastroenterologist's caseload: contribution of the rheumatologist.
Seminars in arthritis and rheumatism 1997;26(6 Suppl 1):11-5.
1997: Hudson N; Taha A S; Russell R I; Trye P; Cottrell J; Mann S G; Swanell A J; Sturrock R D; Hawkey C J
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.
Gastroenterology 1997;112(6):1817-22.
1997: Hawkey C J; Cullen D J; Greenwood D C; Wilson J V; Logan R F
Prescribing of nonsteroidal anti-inflammatory drugs in general practice: determinants and consequences.
Alimentary pharmacology & therapeutics 1997;11(2):293-8.
1997: Donnelly M T; Hawkey C J
Review article: COX-II inhibitors--a new generation of safer NSAIDs?
Alimentary pharmacology & therapeutics 1997;11(2):227-36.
1997: Hawkey C J; Dube L M; Rountree L V; Linnen P J; Lancaster J F
A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis.
Gastroenterology 1997;112(3):718-24.
1997: Hull M A; Knifton A; Filipowicz B; Brough J L; Vautier G; Hawkey C J
Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.
Gut 1997;40(2):204-10.
1996: Hull M A; Hewett P W; Brough J L; Hawkey C J
Isolation and culture of human gastric endothelial cells.
Gastroenterology 1996;111(5):1230-40.
1996: Cole A T; Pilkington B J; McLaughlan J; Smith C; Balsitis M; Hawkey C J
Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.
Gut 1996;39(2):248-54.
1996: Atherton J C; Cullen D J; Kirk G E; Hawkey C J; Spiller R C
Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: implications for antibiotic delivery.
Alimentary pharmacology & therapeutics 1996;10(4):631-5.
1996: Stack W A; Filipowicz B; Hawkey C J
Nitric oxide donating compounds stimulate human colonic ion transport in vitro.
Gut 1996;39(1):93-9.
1996: Taha A S; Hudson N; Hawkey C J; Swannell A J; Trye P N; Cottrell J; Mann S G; Simon T J; Sturrock R D; Russell R I
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
The New England journal of medicine 1996;334(22):1435-9.
1996: McAlindon M E; Muller A F; Filipowicz B; Hawkey C J
Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.
Gut 1996;38(4):518-24.
1996: Murray F E; Hudson N; Atherton J C; Cole A T; Scheck F; Hawkey C J
Comparison of effects of calcium carbasalate and aspirin on gastroduodenal mucosal damage in human volunteers.
Gut 1996;38(1):11-4.
1996: Hawkey C J
Quality of life in users of non-steroidal anti-inflammatory drugs.
Scandinavian journal of gastroenterology. Supplement 1996;221():23-4.
1996: Hawkey C J
Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
Scandinavian journal of gastroenterology. Supplement 1996;220():124-7.
1995: Hull M A; Cullen D J; Hudson N; Hawkey C J
Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration.
Gut 1995;37(5):610-2.
1995: Cole A T; Garlick N M; Galvin A M; Hawkey C J; Robins R A
A flow cytometric method to measure shape change of human neutrophils.
Clinical science (London, England : 1979) 1995;89(5):549-54.
1995: Hudson N; Balsitis M; Everitt S; Hawkey C J
Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs.
Gut 1995;37(2):191-4.
1995: Hudson N; Faulkner G; Smith S J; Logan R F; Hawkey C J
Morbidity and treatment in elderly patients surviving hospital admission with bleeding peptic ulcer.
Gut 1995;37(2):182-6.
1995: Hudson N; Faulkner G; Smith S J; Langman M J; Hawkey C J; Logan R F
Late mortality in elderly patients surviving acute peptic ulcer bleeding.
Gut 1995;37(2):177-81.
1995: Atherton J C; Cockayne A; Balsitis M; Kirk G E; Hawkey C J; Spiller R C
Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine.
Gut 1995;36(5):670-4.
1995: Bardhan K D; Hawkey C J; Long R G; Morgan A G; Wormsley K G; Moules I K; Brocklebank D
Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group.
Alimentary pharmacology & therapeutics 1995;9(2):145-51.
1995: Atherton J C; Washington N; Blackshaw P E; Greaves J L; Perkins A C; Hawkey C J; Spiller R C
Effect of a test meal on the intragastric distribution of urea in the 13C-urea breath test for Helicobacter pylori.
Gut 1995;36(3):337-40.
1994: Hawkey C J
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.
BMJ (Clinical research ed.) 1994;309(6968):1570-1.
1994: Cole A T; Filipowicz B; Hyman-Taylor P; Hawkey C J
Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
Alimentary pharmacology & therapeutics 1994;8(5):521-6.
1994: Atherton J C; Washington N; Bracewell M A; Sutton L J; Greaves J L; Perkins A C; Hawkey C J; Spiller R C
Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor.
Alimentary pharmacology & therapeutics 1994;8(5):489-94.
1994: Hudson N; Everitt S; Hawkey C J
Interobserver variation in assessment of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs.
Gut 1994;35(8):1030-2.
1994: Cole A T; Hawkey C J
Treatment of inflammatory bowel disease from now to the millennium.
Baillière's clinical gastroenterology 1994;8(2):351-79.
1994: Hawkey C J
Review article: aspirin and gastrointestinal bleeding.
Alimentary pharmacology & therapeutics 1994;8(2):141-6.
1994: Neal K R; Briji S O; Slack R C; Hawkey C J; Logan R F
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection.
BMJ (Clinical research ed.) 1994;308(6922):176.
1994: Hawkey C J
Healing and prevention of NSAID-induced peptic ulcers.
Scandinavian journal of gastroenterology. Supplement 1994;201():42-4.
1993: Cullen D; Hawkey C J
Arthrotec for all?
Annals of the rheumatic diseases 1993;52(12):841-2.
1993: Hawkey C J; Long R G; Bardhan K D; Wormsley K G; Cochran K M; Christian J; Moules I K
Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Gut 1993;34(10):1458-62.
1993: Hudson N; Murray F E; Cole A T; Turnbull G M; Lettis S; Hawkey C J
Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
Alimentary pharmacology & therapeutics 1993;7(5):515-21.
1993: Cole A T; Slater K; Sokal M; Hawkey C J
In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis.
Gut 1993;34(9):1210-4.
1993: Boughton-Smith N K; Evans S M; Hawkey C J; Cole A T; Balsitis M; Whittle B J; Moncada S
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
Lancet 1993;342(8867):338-40.
1993: Hudson N; Balsitis M; Everitt S; Hawkey C J
Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.
Gut 1993;34(6):742-7.
1993: Hudson N; Balsitis M; Filipowicz F; Hawkey C J
Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.
Gut 1993;34(6):748-51.
1993: Hudson N; Wilkinson M J; Swannell A J; Steele R J; Hawkey C J
Ileo-caecal ulceration associated with the use of diclofenac slow release.
Alimentary pharmacology & therapeutics 1993;7(2):197-200.
1993: Hull M A; Rawlings J; Murray F E; Field J; McIntyre A S; Mahida Y R; Hawkey C J; Allison S P
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy.
Lancet 1993;341(8849):869-72.
1993: Hawkey C J
Gastroduodenal problems associated with non-steroidal, anti-inflammatory drugs (NSAIDs).
Scandinavian journal of gastroenterology. Supplement 1993;200():94-5.
1992: Cole A T; Brundell S; Hudson N; Hawthorne A B; Mahida Y R; Hawkey C J
Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
Alimentary pharmacology & therapeutics 1992;6(6):707-15.
1992: Murray F E; Stinchcombe S J; Hawkey C J
Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans.
Digestive diseases and sciences 1992;37(8):1228-31.
1992: Murray F E; Stinchcombe S J; Hawkey C J
Development of biliary sludge in patients on intensive care unit: results of a prospective ultrasonographic study.
Gut 1992;33(8):1123-5.
1992: Murray F E; Hull M A; Rawlings J; Hawkey C J; Allison S P
Percutaneous endoscopic gastrostomy feeding.
BMJ (Clinical research ed.) 1992;305(6845):115.
1992: Hawthorne A B; Daneshmend T K; Hawkey C J; Belluzzi A; Everitt S J; Holmes G K; Malkinson C; Shaheen M Z; Willars J E
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.
Gut 1992;33(7):922-8.
1992: Cole A T; Hawkey C J
New treatments in inflammatory bowel disease.
British journal of hospital medicine 1992;47(8):581-90.
1992: Murray F E; Cole A T; Hudson N; Hawkey C J
Possible low-dose-aspirin-induced gastropathy.
Lancet 1992;339(8800):1058-9.
1992: Murray F E; Stinchcombe S J; Hawkey C J
Indomethacin and postprandial gallbladder emptying.
Lancet 1992;339(8797):882.
1992: Hawthorne A B; Boughton-Smith N K; Whittle B J; Hawkey C J
Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.
Gut 1992;33(4):513-7.
1992: Mahida Y R; Ceska M; Effenberger F; Kurlak L; Lindley I; Hawkey C J
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.
Clinical science (London, England : 1979) 1992;82(3):273-5.
1992: Hudson N; Hawthorne A B; Cole A T; Jones P D; Hawkey C J
Mechanisms of gastric and duodenal damage and protection.
Hepato-gastroenterology 1992;39 Suppl 1():31-6.
1992: Cole A T; Brundell S; Hudson N; Hawthorne A B; Mahida Y R; Hawkey C J
Ranitidine, aspirin, food, and the stomach.
BMJ (Clinical research ed.) 1992;304(6826):544-5.
1992: Jones P D; Hudson N; Hawkey C J
Depression of salivary epidermal growth factor by smoking.
BMJ (Clinical research ed.) 1992;304(6825):480-1.
1992: Daneshmend T K; Hawkey C J; Langman M J; Logan R F; Long R G; Walt R P
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.
BMJ (Clinical research ed.) 1992;304(6820):143-7.
1992: Hawkey C J; Mahida Y R; Hawthorne A B
Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators.
Agents and actions 1992;Spec No():C22-6.
1991: Mahida Y R; Kurlac L; Gallagher A; Hawkey C J
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.
Gut 1991;32(12):1531-4.
1991: Hawkey C J; Hawthorne A B; Hudson N; Cole A T; Mahida Y R; Daneshmend T K
Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.
Clinical science (London, England : 1979) 1991;81(4):565-73.
1991: Hawkey C J
The place of cisapride in therapeutics: an interim verdict.
Alimentary pharmacology & therapeutics 1991;5(4):351-6.
1991: Hawthorne A B; Mahida Y R; Cole A T; Hawkey C J
Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
British journal of clinical pharmacology 1991;32(1):77-83.
1991: Mahida Y R; Lamming C E; Gallagher A; Hawthorne A B; Hawkey C J
5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.
Gut 1991;32(1):50-4.
1991: Hudson N; Daneshmend T K; Hurst S; Bhaskar N K; Brown N S; Hawkey C J
Effect of smoking on prostaglandin, thromboxane and leukotriene synthesis by human gastric mucosa.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():777-9.
1990: Mahida Y R; Gallagher A; Kurlak L; Hawkey C J
Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.
Clinical and experimental immunology 1990;82(1):75-80.
1990: Hawthorne A B; Filipowicz B L; Edwards T J; Hawkey C J
High dose eicosapentaenoic acid ethyl ester: effects on lipids and neutrophil leukotriene production in normal volunteers.
British journal of clinical pharmacology 1990;30(2):187-94.
1990: Daneshmend T K; Stein A G; Bhaskar N K; Hawkey C J
Abolition by omeprazole of aspirin induced gastric mucosal injury in man.
Gut 1990;31(5):514-7.
1990: Hawkey C J
Non-steroidal anti-inflammatory drugs and peptic ulcers.
BMJ (Clinical research ed.) 1990;300(6720):278-84.
1989: Hawkey G M; Hawkey C J
Effect of information leaflets on knowledge in patients with gastrointestinal diseases.
Gut 1989;30(11):1641-6.
1989: Kitchingman G K; Prichard P J; Daneshmend T K; Walt R P; Hawkey C J
Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.
British journal of clinical pharmacology 1989;28(5):581-5.
1989: Daneshmend T K; Prichard P J; Bhaskar N K; Millns P J; Hawkey C J
Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine.
Gastroenterology 1989;97(4):944-9.
1989: Daneshmend T K; Stein A G; Bhaskar N K; Hawkey C J
Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans.
British journal of clinical pharmacology 1989;28(1):109-12.
1989: Prichard P J; Kitchingman G K; Walt R P; Daneshmend T K; Hawkey C J
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.
BMJ (Clinical research ed.) 1989;298(6672):493-6.
1988: Hawkey C J; Hawthorne A B
Medical treatment of ulcerative colitis: scoring the advances.
Gut 1988;29(10):1298-303.
1988: Prichard P J; Poniatowska T J; Willars J E; Ravenscroft A T; Hawkey C J
Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding.
British journal of clinical pharmacology 1988;26(2):167-72.
1988: Hawkey C J; Somerville K W; Marshall S
Prophylaxis of aspirin-induced gastric mucosal bleeding with ranitidine.
Alimentary pharmacology & therapeutics 1988;2(3):245-52.
1988: Cox J; Daneshmend T K; Hawkey C J; Logan R F; Walt R P
Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease.
Gut 1988;29(5):686-8.
1988: Hawkey C J; Kemp R T; Walt R P; Bhaskar N K; Davies J; Filipowicz B
Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins.
Gastroenterology 1988;94(4):948-54.
1987: Hawkey C J
Review: acute human models of gastric mucosal injury.
Alimentary pharmacology & therapeutics 1987;1(6):593-606.
1987: Walt R P; Kemp R T; Filipowicz B; Davies J G; Bhaskar N K; Hawkey C J
Gastric mucosal protection with selective inhibition of thromboxane synthesis.
Gut 1987;28(5):541-4.
1987: Walt R P; Pounder R E; Hawkey C J; Santana I A; Somerville K W; Logan R F; Long R G; Langman M J
Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer.
Alimentary pharmacology & therapeutics 1987;1(2):161-6.
1986: Hawkey C J; Prichard P J; Somerville K W
Strategies for preventing aspirin-induced gastric bleeding.
Scandinavian journal of gastroenterology. Supplement 1986;125():170-3.
1985: Walt R P; Reynolds J R; Langman M J; Smart H L; Kitchingman G; Somerville K W; Hawkey C J
Intravenous omeprazole rapidly raises intragastric pH.
Gut 1985;26(9):902-6.

Sign-in to see more